🔬 Exciting news: We've awarded $2.8M in research grants to 13 investigators pursuing breakthrough science in neuroendocrine cancer. Read today's announcement: ow.ly/vnMM50Y55hY
#NeuroendocrineCancer #NETResearch #NeuroendocrineTumor #NETs #NECs #NENs
Poorly differentiated neuroendocrine carcinomas relapse almost universally after chemotherapy. 2026 @NANETS1 BTSI awardee Majid Monemy, PhD, is testing whether inhibiting DUSP1 restores JNK-driven apoptosis and platinum sensitivity. Funded by @CureNETs. 🔗ow.ly/j6Zt50ZRwo4
Attention #neuroendocrinecancer early career researchers: this NETRF-funded grant is now open for applications through August 31st. Apply now ➡️ow.ly/U30750Zun7c
#NETs #cancerresearch #researchgrants #nuclearmedicine #NETCancer
Go inside a #neuroendocrinecancer tumor board. Join the Know Your NETs livestream now ➡️ netrf.org/events/know-your-n…
It's almost time! Know Your NETs starts TODAY at 11 AM ET!
Join the livestream for our largest #neuroendocrinecancer patient and caregiver conference of the year.
➡️ow.ly/pgvN50ZpaZv
🚨Attention #Neuroendocrinecancer researchers: NETRF has just launched its first Early Detection Request for Applications (RFA).
Letters of Intent (LOIs) Due: Monday, June 15, 2026, 5 PM ET
Learn more ➡️ ow.ly/kQl750Z1a8B
A NETRF-backed study by Carl Gay, MD, PhD, of @MDAnderson looks at how chemotherapy may lead to treatment resistance and relapse in small cell lung cancer.
mdanderson.org/newsroom/rese…
#neuroendocrinecancer #sclc #cancerresearch #NETs #breakthroughstodaycurestomorrow
Attention #Neuroendocrinecancer Researchers: The @NANETS Basic/Translational Science Investigator Grant sponsored by NETRF (@CureNETs) is open for applications through 6/26/26 Learn more ➡️ ow.ly/z58Z50YOekh
NETRF is at #AACR26 in San Diego this week, with Chief Science Officer @greeneannac , Board Member Carrie Camino, and several NETRF-funded researchers raising awareness of #neuroendocrinecancer and advancing science.
#NETRF #CancerResearch #NETs #NENs #NECs #PatientEducation
Neuroendocrine Cancer Research Foundation retweeted
➡️ EP-NEC patients require expert care from specialists knowledgeable in #neuroendocrine carcinoma
➡️ Generic care is insufficient to address the aggressive nature and unique challenges of this disease
What else do HCPs need to know to support pts w/ extrapulmonary neuroendocrine carcinoma?
📺 Watch the video to find out
From Jessica Thomas, Director of Patient Education at the Neuroendocrine Tumor Research Foundation
🤝Endorsed by @CureNETs & Minkahz NETs Mission
See more of this programme: cor2ed.com/net-connect/progr…
Supported by an Independent Educational Grant from Boehringer Ingelheim
#MedEd #OncTwitter
2025 Investigator Award Grantee @yuanyuan_qiao discusses her NETRF-funded research to find more effective treatments for #GEP-NETs
University of Michigan researchers @yuanyuan_qiao and @ArulChinnaiyan have identified a new target that can suppress tumor growth in gastroenteropancreatic neuroendocrine tumors.
Learn how their findings can be used to develop new treatment methods: michmed.org/VdBz7.
Congratulations to @HuiYu95592845 Hui Yu, MD, PhD, of @CUAnschutz on her NETRF Mentored Research Award award for her research exploring how DIPNECH can progress to lung neuroendocrine tumors.
Learn more: ow.ly/HQY950YzPya
#DIPNECH #LungNETs #NETRFGrantee
Tijana Jovanovic-Talisman, PhD, is among this year's NETRF Pilot Award grantees, and her work to improve diagnostics for #neuroendocrinecancer is deeply personal.
Read more: ow.ly/jZHS50YyMjJ
#NETRFGrantee
The NIH/NCI Neuroendocrine Tumor (NET) SPORE @UIHealthcare is accepting Letters of Concept through Mar. 23 for two funding mechanisms aimed at advancing translational NET research. Learn more ow.ly/YvgL50Yw4Fp
#neuroendocrinecancer #NETresearch #grantopportunities
Congratulations to Chiara Mazziotta, PhD, of @DanaFarber on her NETRF Mentored Research Award for her research on Merkel cell carcinoma, a rare neuroendocrine skin cancer.
Learn more about Dr. Mazziotta’s research: ow.ly/MrqO50YuXuZ
#NETRFGrantee #Merkelcellcarcinoma
Reseachers: don't miss the LOI deadline - Monday, March 12. More info below.
🚨 NETRF 2026 RFAs are now open!
New this year: dedicated funding for #translationalimmunotherapy, alongside our broad support for NEN research.
🗓 LOIs due March 16, 2026
📍 Apply via Proposal Central
➡️ ow.ly/NLa250YaqBw
#neuroendocrinecancer #GrantOpportunities
🎉Congratulations to Suzann Duan, PhD, at UC Irvine, on her NETRF Investigator Award for research exploring how aging impacts gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Learn more: ow.ly/tQLf50Yt6BR
#NETRFGrantee #Neuroendocrinecancer #GEP-NETs
Congrats to NETRF Mentored Research Awardee Yeonghwan Kim, PhD, Postdoctoral Fellow at Columbia University, for his research exploring why some #PanNETs resist treatment.
Read more ➡️ ow.ly/7TRZ50YrPeE
#NETRFGrantee #NETs #Neuroendocrinecancer
🎉Congratulations to Kirsten Kübler, MD, PhD, on her NETRF Pilot award for her research on the impacts of metaplasia on neuroendocrine neoplasms.
Read more about Dr. Kübler’s research: ow.ly/ElL650YpH1P
#panNETs #NETRFGrantee #neuroendocrinecancer
Neuroendocrine Cancer Research Foundation retweeted
🚨 @CureNETs 2026 LOIs are due soon! New this year: dedicated funding for #translationalimmunotherapy, alongside our broad support for NEN research.
💻LOIs due March 16, 2026
📢Learn more: ow.ly/NLa250YaqBw
🎉Congratulations to NETRF Pilot Award recipient Thomas Walter, MD, PhD (Cancer Research Center of Lyon) who is investigating PRMT5-blocking drugs in NETs in the hopes of identifying new treatments.
Read more ➡️ ow.ly/mr2o50YoAVm
#NETRFGrantee #neuroendocrinecancer





















